Company intelligence / Profile preview

VISIE

Austin, Texas, United Statesvisievision.com ↗

Ownership: Private
Development stage: Other

Overview

VISIE’s optical scanner platform delivers real-time, sub-millimeter precision imaging to enable more accurate robotic-assisted orthopedic, neuro, and spine surgeries. The company claims its system can gather over one million data points in a second with “Snap Registration” and offers continuous anatomic auto-tracking. Bench tests suggest the technology can differentiate tissue types without contact or dyes. The company has raised $8.2M+ to support productization and regulatory submission efforts[1][3].

No published clinical trial results yet; device development ongoing toward FDA submission[3].

Therapeutic areas: NeurologyOther
Modalities: DeviceNon-pharmacological therapy (enabling technology for surgical robotics and navigation)
Industry: Medical Imaging

Partnerships

NVIDIA Inception program participant

Beyond the preview

Go deeper on VISIE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VISIE.

Explore the full profile